ARTELO BIOSCIENCES, INC.: 10-Q filed 2020-07-13

Name: ARTELO BIOSCIENCES, INC.: 10-Q filed 2020-07-13
Creator: ARTELO BIOSCIENCES, INC.

What ARTELO BIOSCIENCES, INC. reported in its quarterly report filed 2020-07-13 (fiscal Q3 2020): 29 published measures, 86 facts as tagged in accession 0001640334-20-001749.

This filing

Form: 10-Q (quarterly report)
Filed: 2020-07-13
Fiscal period: fiscal Q3 2020
Accession: 0001640334-20-001749 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ARTELO BIOSCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2020-05-31	3,493,527	USD
At 2019-08-31	6,482,726	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2020-05-31	3,225,070	USD
At 2020-02-29	3,708,054	USD
At 2019-11-30	4,963,364	USD
At 2019-08-31	5,461,213	USD
At 2019-05-31	134,379	USD
At 2019-02-28	-692,174	USD
At 2018-11-30	-475,164	USD
At 2018-08-31	-134,974	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2020-05-31	1,279,256	USD
At 2019-08-31	4,423,965	USD
At 2019-05-31	286,439	USD
At 2018-08-31	337,424	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2020-03-01 to 2020-05-31	-951,191	USD	92
2019-09-01 to 2020-05-31	-3,627,678	USD	274
2019-12-01 to 2020-02-29	-1,370,126	USD	91
2019-09-01 to 2019-11-30	-1,306,361	USD	91
2019-03-01 to 2019-05-31	-344,883	USD	92
2018-09-01 to 2019-05-31	-1,326,575	USD	273
2018-12-01 to 2019-02-28	-424,789	USD	90
2018-09-01 to 2018-11-30	-556,903	USD	91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2019-09-01 to 2020-05-31	-3,474,667	USD	274
2018-09-01 to 2019-05-31	-1,731,580	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2019-09-01 to 2020-05-31	270,771	USD	274
2018-09-01 to 2019-05-31	1,679,772	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2019-09-01 to 2020-05-31	-1,176	USD	274
2018-09-01 to 2019-05-31	-688	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2020-05-31	-8,438,434	USD
At 2019-08-31	-4,810,756	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2019-09-01 to 2020-05-31	USD	274
2019-03-01 to 2019-05-31	USD	92
2018-09-01 to 2019-05-31	USD	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2020-05-31	1,484	USD
At 2019-08-31	721	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2019-09-01 to 2020-05-31	326,398	USD	274
2018-09-01 to 2019-05-31	376,095	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2020-03-01 to 2020-05-31	-951,395	USD	92
2019-09-01 to 2020-05-31	-3,658,377	USD	274
2019-03-01 to 2019-05-31	-941,288	USD	92
2018-09-01 to 2019-05-31	-2,256,110	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2020-05-31	1,452,626	USD
At 2019-08-31	4,442,588	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2020-05-31	268,457	USD
At 2019-08-31	1,021,513	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2019-08-31	639,417	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2020-03-01 to 2020-05-31	951,395	USD	92
2019-09-01 to 2020-05-31	3,658,377	USD	274
2019-03-01 to 2019-05-31	941,288	USD	92
2018-09-01 to 2019-05-31	2,256,110	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2020-03-01 to 2020-05-31	265,204	USD	92
2019-09-01 to 2020-05-31	1,646,920	USD	274
2019-03-01 to 2019-05-31	184,204	USD	92
2018-09-01 to 2019-05-31	858,224	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2020-05-31	3,733,604	shares
At 2019-08-31	3,353,616	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2020-05-31	11,609,266	USD
At 2019-08-31	10,278,421	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2020-05-31	50,504	USD
At 2019-08-31	-9,806	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2020-05-31	1,144	USD
At 2019-08-31	792	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2020-05-31	2,039,417	USD
At 2019-08-31	2,039,417	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2020-03-01 to 2020-05-31	-916,644	USD	92
2019-09-01 to 2020-05-31	-3,567,368	USD	274
2019-03-01 to 2019-05-31	-344,112	USD	92
2018-09-01 to 2019-05-31	-1,324,522	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2020-03-01 to 2020-05-31	382,543	USD	92
2019-09-01 to 2020-05-31	1,225,952	USD	274
2019-03-01 to 2019-05-31	402,803	USD	92
2018-09-01 to 2019-05-31	666,226	USD	273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2020-03-01 to 2020-05-31	124	USD	92
2019-09-01 to 2020-05-31	372	USD	274
2019-03-01 to 2019-05-31	243	USD	92
2018-09-01 to 2019-05-31	383	USD	273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2020-03-01 to 2020-05-31	204	USD	92
2019-09-01 to 2020-05-31	30,699	USD	274
2019-03-01 to 2019-05-31	596,405	USD	92
2018-09-01 to 2019-05-31	929,535	USD	273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2019-09-01 to 2020-05-31	0	USD	274
2018-09-01 to 2019-05-31	0	USD	273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2019-09-01 to 2020-05-31	0	USD	274
2018-09-01 to 2019-05-31	0	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2019-09-01 to 2020-05-31	380,678	USD	274
2018-09-01 to 2019-05-31	1,675,637	USD	273

Inspect the source

Entity: ARTELO BIOSCIENCES, INC. / CIK 0001621221
Captured: 2026-09-21T17:20:46.444Z
SEC response SHA-256: 8c305444d4d0d2c4ad293d87d813338ddd6341ab9515d1faff9d1e445f967777

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001621221.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))